Oncology & Cancer

Multiple types of resistance to new lung cancer drug identified

After identifying three different types of resistance to a promising investigational lung cancer drug in a phase 1 trial, a team of researchers led by Dana-Farber Cancer Institute scientists say new targeted inhibitors and ...

page 15 from 24